| abstract |
The invention provides new compound and as medicine, more particularly for preventing or treat the new compound of neurodegenerative illness, this neurodegenerative illness is more particularly for some nervous disorders (such as the illness that is referred to as the illness of Protein tau disease and is generated as feature with cytotoxin alpha-synapse nucleoprotein amyloid). The invention still further relates to described new compound for the manufacture of the purposes that can be used for the medicine for the treatment of this class neurodegenerative illness. The invention further relates to the pharmaceutical composition that comprises described new compound and the method for the preparation of described new compound. |